| Literature DB >> 25685907 |
Lorena Almagro1, Francisco Fernández-Pérez2, Maria Angeles Pedreño3.
Abstract
Catharanthus roseus is a medicinal plant belonging to the family Apocynaceae which produces terpenoid indole alkaloids (TIAs) of high medicinal importance. Indeed, a number of activities like antidiabetic, bactericide and antihypertensive are linked to C. roseus. Nevertheless, the high added value of this plant is based on its enormous pharmaceutical interest, producing more than 130 TIAs, some of which exhibit strong pharmacological activities. The most striking biological activity investigated has been the antitumour effect of dimeric alkaloids such as anhydrovinblastine, vinblastine and vincristine which are already in pre-, clinical or in use. The great pharmacological importance of these indole alkaloids, contrasts with the small amounts of them found in this plant, making their extraction a very expensive process. To overcome this problem, researches have looked for alternative sources and strategies to produce them in higher amounts. In this sense, intensive research on the biosynthesis of TIAs and the regulation of their pathways has been developed with the aim to increase by biotechnological approaches, the production of these high added value compounds. This review is focused on the different strategies which improve TIA production, and in the analysis of the beneficial effects that these compounds exert on human health.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25685907 PMCID: PMC6272713 DOI: 10.3390/molecules20022973
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of the four Vinca alkaloids vincristine (A), vinblastine (B), vinorelbine (C) and vinflunine (D). The arrow indicates the principal difference between vincristine (A) and vinblastine (B). The arrow heads indicate the principal difference between vinorelbine (C) and vinflunine (D).
Strategies to increase the production of TIAs in C. roseus.
| Material | Strategy | Total TIAs | Observations | Refs |
|---|---|---|---|---|
| Compact callus cluster | Medium supplemented with mannitol (250 mM) | 4.13-fold increase (75 mg/L) | 5.05-fold increase in catharanthine (19.7 mg/L) | [ |
| 2.77-fold increase in serpentine (13.6 mg/L) | ||||
| 4.54-fold increase in ajmalicine (42.3 mg/L) | ||||
| Medium supplemented with KCl (4g/L) | 3.15-fold increase (57.8 mg/L) | 3.15-fold increase in catharanthine (12.3 mg/L) | ||
| 2.42-fold increase in serpentine (11.9 mg/L) | ||||
| 3.62-fold increase in ajmalicine (33.5 mg/L) | ||||
| Compact callus cluster | Medium supplemented with sucrose (50 g/L) | 1.16-fold increase (46.7 mg/L) | 1.25-fold increase in serpentine (10 mg/L) | [ |
| 1.20-fold increase in ajmalicine (14.5 mg/L) | ||||
| Suspension cultured cells | High cell density (200 g FW/L) | ND | 120-fold increase in ajmalicine (60 mg/L) | [ |
| Immobilized cells | High cell density (100 g FW/L) | ND | 2-fold increase in ajmalicine (120 mg/L) | [ |
| Immobilized cells | Elicitation with | ND | 45-fold increase in ajmalicine (90 mg/L) | [ |
| Shoot culture | MS medium supplemented with plant growth regulators | ND | The concentrations of 8.90 µM BA and 2.85 µM IAA increased the production of ajmalicine (0.85 g/L) | [ |
| Callus | MS medium supplemented with plant growth regulators | ND | The concentrations of 2.21 µM BA and 5.7 µM IAA increased the production of catharanthine (0.12 mg/g DW) | [ |
| ajmalicine (0.35 mg/g DW) | ||||
| vindoline (0.19 mg/g DW) | ||||
| serpentine (0.53 mg/g DW) | ||||
| Immobilized cells | Variation of O2 and CO2 concentration | ND | 1.1-fold increase in ajmalicine (275 g/L ) | [ |
| Suspension cultured cells | Feeding with loganin and triptamine | ND | 17.73-fold increase in strictosidine (53.19 µmo/g DW) | [ |
| 6.4-fold increase in ajmalicine (3.2 µmol/g DW) | ||||
| Compact callus cluster | Feeding with succinic acid (10 mM) | 4.86-fold increase (73 mg/L) | 3.5-fold increase in catharanthine (7 mg/L) | [ |
| 7.5-fold increase in serpentine (15 mg/L) | ||||
| 16-fold increase in ajmalicine (32 mg/L) | ||||
| Feeding with tryptamine (3.12 mM) | 3.86-fold increase (58 mg/L) | 2.5-fold increase in catharanthine (5 mg/L) | ||
| 7-fold increase in serpentine (14 mg/L) | ||||
| 15.5-fold increase in ajmalicine (31 mg/L) | ||||
| Feeding with tryptophan (2.44 mM) | 5.53-fold increase (68 mg/L) | 2.5-fold increase in catharanthine (5 mg/L) | ||
| 6-fold increase in serpentine (12 mg/L) | ||||
| 14-fold increase in ajmalicine (28 mg/L) | ||||
| Hairy root culture | Feeding with geraniol (0.5 mM) | ND | 1.5-fold increase in tabersonine (1.4 mg/g DW) | [ |
| Hairy root culture | Elicitation with sodium nitroprusside (0.1 mM) | 1.42-fold increase (3.7 mg/g DW) | 2-fold increase in lochnericine (1 mg/g DW) | [ |
| 2.3-fold increase in tabersonine (0.7 mg/g DW) | ||||
| 2-fold increase in ajmalicine (0.7 mg/g DW) | ||||
| Suspension cultured cells | Elicitation with MeJA (101.9 µM) | 1.33-fold increase (2.2 mg/g DW) | 2-fold increase in tabersonine (3.8 mg/g DW) | [ |
| Suspension cultured cells | Elicitation with MeJA (100 µM) | ND | 27.44-fold increase in ajmalicine (137.2 mg/L) | [ |
| 11.12-fold increase in catharanthine (55.6 mg/L) | ||||
| Hairy root culture | Elicitation with MeJA (250 µM) | 1.32-fold increase (49 mg/L) | 7-fold increase in ajmalicine (6.34 mg/g DW) | [ |
| 2.9-fold increase in serpentine (1.71 mg/g DW) | ||||
| 3-fold increase in ajmaline (12 mg/g DW) | ||||
| 3-fold increase in catharanthine (4.34 mg/g DW) | ||||
| Suspension cultured cells | Elicitation with | ND | 7.9-fold increase in ajmalicine (0.166 mg/g DW) | [ |
| Suspension cultured cells | Elicitation with the protein of | ND | 4-fold increase in catharanthine (20 mg/L) | [ |
| Suspension cultured cells | Elicitation with CDs | ND | 40-fold increase in ajmalicine (200 mg/L) | [ |
| 17-fold increase in catharanthine (85 mg/L) | ||||
| Suspension cultured cells | Elicitation with UV-B light | ND | 3-fold increase in catharanthine (0.12 mg/g DW) | [ |
| 117.6-fold increase in vindoline (0.06 mg/g DW) | ||||
| Suspension cultured cells | Elicitation with UV-C light | ND | 18-fold increase in ajmalicine (90 mg/L) | [ |
| 10-fold increase in catharanthine (50 mg/L) | ||||
| Plant | Elicitation with chromium (50 µM) | ND | 1.5-fold increase in vincristine (2 µg/g DW) | [ |
| 2.16-fold increase in vinblastine (2.25 µg/g DW) | ||||
| Suspension cultured cells | Elicitation with | 3.84-fold increase (96 mg/L) | 21-fold increase in ajmalicine (63 mg/L) | [ |
| 17-fold increase in catharanthine (17 mg/L) | ||||
| Elicitation with malate and sodium alginate | 3.28-fold increase (82 mg/L) | 13.6-fold increase in ajmalicine (41 mg/L) | ||
| 26-fold increase in catharanthine (26 mg/L) | ||||
| Suspension cultured cells | Elicitation with MeJA and CDs | ND | 90-fold increase in ajmalicine (450 mg/L) | [ |
| 31-fold increase in catharanthine (155 mg/L) | ||||
| Elicitation with MeJA, CDs and UV-C light | ND | 2.3-fold increase in ajmalicine (1040 mg/L) (85 mg/g DW) | ||
| 1.26-fold increase in catharanthine (196 mg/L) (10 mg/g DW) | ||||
| Suspension cultured cells | Overexpression of | 24.6 fold in increase (123 mg/L) | _ | [ |
| Suspension cultured cells | Overexpression of | 125 fold in increase (625 mg/L) | _ | [ |
| Hairy root culture | Overexpression of | ND | 4-fold increase in hörhammericine (0.16 mg/g DW) | [ |
| Hairy root culture | Overexpression of CrPrx | 1.5-fold increase (85 mg/g DW) | 5-fold increase in serpentine (3.7 mg/g DW) | [ |
| 3-fold increase in ajmalicine (0.35 mg/g DW) | ||||
| Hairy root culture | Overexpression of | NV | 1.66-fold increase in ajmalicine (1.5 mg/g DW) | [ |
| 1.66-fold increase in lochnericine (1 mg/g DW) | ||||
| Overexpression of | NV | 1.25-fold increase in lochnericine (2.5 mg/g DW) | ||
| Overexpression of | 0.0072 mg/g DW | 1.35-fold increase in tabersonine (0.9 mg/g DW) | ||
| 1.15-fold increase in lochnericine (1.4 mg/g DW) | ||||
| Overexpression of | 0.015 mg/g DW | 1.16-fold increase in tabersonine (1.7 mg/g DW) | ||
| 1.18-fold increase in lochnericine (2 mg/g DW) | ||||
| Leaves | Transient overexpression of | ND | 1.6-fold increase in vindoline (2.5 mg/g DW) | [ |
| Tobacco cell cultures | Overexpression of | ND | Enhancement in strictosidine (5.3 mg/L) | [ |
| Overexpression of | ND | Enhancement in strictosidine (21.2 mg/L) | ||
| Overexpression of | ND | Enhancement in strictosidine (1.95 mg/g FW) | [ | |
| Overexpression of | ND | Enhancement in strictosidine (2000 mg/L) | [ | |
| Hairy root culture | Overexpression of transcription factor | ND | 3-fold increase in serpentine (0.291 mg/g DW) | [ |
| 10-fold increase in ajmalicine (0.015 mg/g DW) | ||||
| Leaves | Transient overexpression of transcription factor | ND | 3.52-fold increase in serpentine (0.061 mg/g DW) | [ |
| 2.66-fold increase in vindoline (4.1 mg/g DW) | ||||
| 1.44-fold increase in catharanthine (1.3 mg/g DW) | ||||
| 2-fold increase in vincristine (1.75 mg/g DW) | ||||
| Hairy root culture | Overexpression of transcription factor | ND | 2.5-fold increase in catharanthine (5.6 mg/g DW) | [ |
| Hairy root culture | Overexpression of transcription factor | ND | 2-fold increase in catharanthine (4.8 mg/g DW) | [ |
| Transgenic plant | Overexpression of | ND | 3.03-fold increase in vindoline (2.1 mg/g DW) | [ |
| 2.29-fold increase in catharanthine (4.6 mg/g DW) | ||||
| 6.30-fold increase in ajmalicine (0.315 mg/g DW) | ||||
| 1.08-fold increase in anhydrovinblastine (10.2 mg/g DW) | ||||
| 10.2-fold increase in vinblastine (0.27 mg/g DW) |
Abbreviations: DW, dry weight; FW, fresh weight; ND, not determined; NV, no variation; TIAs, Terpenoid indole alkaloids; STR, strictosidine synthase; TDC, tryptophan decarboxylase; DAT, deacetylvindoline 4-O-acetyltransferase; CrPrx, C. roseus peroxidase; DXS, 1-deoxy-D-xylulose-synthase; G10H, geraniol-10-hydroxylase; ASα, anthranilate synthase α subunit; GPPS, Geranyl diphosphate synthase; CrMPK3, C. roseus mitogen activated protein kinase 3, MeJA, methyl jasmonate; CDs, cyclodextrins; BA, benzyl adenine; IAA, indole-3-acetic acid.
Figure 2Gene regulation scheme of transcription factors involved in the TIA biosynthethic pathways. AS, anthranilate synthase; TDC, tryptophan decarboxylase; G10H, geraniol 10-hydroxilase; SLS, secologanin synthase; STR, strictosidine synthase; SGD, strictosidine β-D-glucosidase, T16H, tabersonine 16-hydroxylase, OMT, 16-hydoxytabersonine 16-O-methyltransferase; NMT, N-methyltransferase; D4H, desacetoxyvindoline 4-hydroxylase; DAT, deacetylvindoline 4-O-acetyltransferase; Prx, peroxidase.